Magic marker? Anyting but. It’s science baby!
And that’s why the Path is Critical.
(As a 40-something male this one really strikes close to home.)
Here’s the news
Scientists are reporting that they have detected a variant gene associated with prostate cancer, a finding that may make possible a diagnostic test to help decide which patients are the best candidates for aggressive treatment. The discovery by Decode Genetics, a gene-finding company based in Iceland, may also help explain why African-Americans, in whom the variant is more common, have a greater incidence of the disease.
Here’s a link to the rest of the story …